Human Natural Killer T Cells Infiltrate into the Skin at Elicitation Sites of Allergic Contact Dermatitis  by Gober, Michael D. et al.
Human Natural Killer T Cells Infiltrate into the Skin at
Elicitation Sites of Allergic Contact Dermatitis
Michael D. Gober1, Rita Fishelevich1, Yuming Zhao1, Derya Unutmaz2,3 and Anthony A. Gaspari1,4
The purpose of this study is to identify invariant natural killer T cells (NKT cells) in cellular infiltrate of human
allergic contact dermatitis (ACD) skin challenge sites. Skin biopsy specimens were taken from positive patch
test reactions from 10 different patients (9 different allergens) and studied by immunochemistry, real-time PCR,
nested PCR, and in situ hybridization to identify NKT cells and the cytokines associated with this cell type.
Invariant NKT cells were identified in all the 10 skin biopsy specimens studied, ranging from 1.72 to 33% of the
cellular infiltrate. These NKTcells were activated in all cases, as they expressed cytokine transcripts for IFN-g and
IL-4. Invariant NKT cells are present in ACD, regardless of the allergen that triggers the reaction, and are in an
activated state. We conclude that innate immunity plays a role in late phases of type IV hypersensitivity
reactions and may be responding to self-lipids released during allergic inflammation. These data complement
the previous work by other investigators that suggest that NKT cells are important in the early cellular response
during primary immune responses to allergens. Herein, it is demonstrated that NKT cells are constantly present
during the late elicitation phase of human type IV hypersensitivity reactions.
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INTRODUCTION
Contact hypersensitivity (CHS) is an example of a cell-
mediated immune response against hapten-self complexes
that are presented to the immune system by skin-derived
dendritic cells, such as Langerhans cells and dermal dendritic
cells, that traffic modified self-molecules to the local lymph
node. Upon interactions with skin-associated lymphoid
tissue, these hapten-bearing antigen-presenting cells (APCs)
educate naı¨ve, conventional TCR a/b-bearing CD4þ and
CD8þ T lymphocytes to become allergen-specific memory
and effector T lymphocytes (afferent phase of CHS) (Wata-
nabe et al., 2002). During the elicitation phase, allergen-
specific T lymphocytes are reactivated in the local lymph
nodes and migrate to the challenge site to produce cytokines
and cytotoxic damage to the skin, resulting in the clinical
signs and symptoms of CHS: erythema, edema, infiltration,
and pruritus (Wakem and Gaspari, 2000).
There is a limited amount of information about the nature
and the frequency of hapten-reactive lymphocytes in the skin
lesions of CHS. In a guinea pig model of CHS, the frequency
of allergen-specific T cells was approximately 1% of the
infiltrate (McCluskey et al., 1963). Experimental CHS in
human subjects with documented allergy to poison ivy
indicates that the frequency of hapten-reactive conventional
T lymphocytes in the peripheral blood is low (in the range of
1/10,000 clonal frequency) and that there is a relative
enrichment of this subset of allergen-reactive T lymphocytes
in positive patch test sites (10- to 100-fold increase above the
frequency of that found in the peripheral blood) (Kalish and
Morimoto, 1989; Kalish, 1990; Kalish and Johnson, 1990).
Despite this relative enrichment of allergen-specific T cells in
the skin-challenge sites, the frequency of the allergen-specific
cells remains very low, despite a variably dense lymphocytic
infiltrate that is observed in histologic sections of human CHS
(Lachapelle, 1973). The nature of the lymphocytic infiltrate in
the elicitation phase of CHS has been presumed to be
autoreactive (Kalish, 1991), yet the antigen specificity of such
an infiltrate has not been determined, nor has the nature of the
self-antigens unmasked during CHS reactions been elucidated.
Natural killer T cells (NKT cells) are a unique subset of
lymphocytes that express a TCR a/b, with a restricted
repertoire, commonly Va24 and Vb11 in humans (Godfrey
et al., 2004). They may be double negative for CD4/CD8 or
may be single positive for CD4 or CD8. NKT cells recognize
glycolipids, both microbial derived, or self glycolipids,
presented in the context of CD1d, a class I major
histocompatibility complex-like molecule (Sieling, 2000).
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After activation, NKT cells produce polarizing cytokines such
as IFN-g and/or IL-4 and therefore have the capacity to
immunoregulate adaptive immunity (Sieling, 2000). Because
human epidermal keratinocytes (KCs) constitutively express
CD1d (Fishelevich et al., 2006), we asked the question
whether NKT cells contribute to the cellular infiltrate of
allergic contact dermatitis (ACD).
Herein, we report that CD1d gene expression is increased
in elicitation sites of ACD relative to normal skin. Similarly,
both CD161 gene expression and variable region of TCR a
chain-24 (Va24)–junctional region of TCR a chain-Q (JaQ)
TCR gene expression in skin lesions of ACD are increased
relative to normal skin. Digital image analysis of in situ
staining of ACD skin biopsy specimens indicated a variable
but significant presence of Va24þ /CD2þ or Vb11þ /
CD2þ double-positive NKT cells, at a frequency that ranged
from 1.72% to as high as 33% of the total of the T-
lymphocyte infiltrate. The genes encoding the Th1 and Th2
polarizing cytokines such as IFN-g and IL-4 were identified in
skin biopsy specimens. Double in situ hybridization (ISH)
with the invariant NKT-cell antigen receptor Va24 or JaQ
(green) to identify NKT cells and IFN-g or IL-4 (red) indicated
that NKT cells were, in part, the source of both of these
cytokine transcripts. These data indicate that invariant NKT
cells are commonly present in the T-lymphocyte infiltrate of
ACD and contribute cytokines to the inflammatory reaction.
To our knowledge, it is unreported previously that this innate
immune cell type plays a role in the immune mechanisms of
the height of the elicitation phase of human ACD.
RESULTS
To determine whether NKT cells infiltrated into skin lesions of
ACD, gene expression profiles of biopsy specimens from
clinically normal skin and ACD sites (see Table 1) were
studied utilizing real-time PCR. Compared to paired clinically
normal skin, CD1d gene expression was significantly
increased in patch test reactions, but varied in the magnitude
of the increase in gene expression (ranging from 1.2- to 6.4-
fold more than that in normal skin) (Figure 1a). Psoriatic
plaque and paired uninvolved skin were utilized as a positive
control for the detection of increased CD1d gene expression
(Bonish et al., 2000). CD1d gene expression is increased in
all skin biopsy specimens of ACD relative to normal skin.
Frozen sections of biopsy specimens taken from ACD were
stained to confirm the increased expression of CD1d and to
determine the cell types that expressed this molecule (data
not shown). Consistent with data previously reported on ACD
secondary to Rhus antigen (Bonish et al., 2000), there was
increased expression of CD1d by most epidermal KCs. These
data indicate that increased CD1d expression by KCs and
infiltrating bone-marrow-derived cells is a common feature
of ACD.
CD161 is type II membrane glycoprotein that is expressed
by most NK cells and NKT cells (Metelitsa, 2004). CD161
gene expression was also studied in psoriatic skin and five
ACD specimens. Robust CD161 gene expression was
detected in all the five ACD specimens (2.97- to 13.20-fold
more than in paired normal skin) (Figure 1b). There was also
robust CD161 gene expression in a biopsy specimen from a
psoriatic lesion (14.33-fold more than in uninvolved skin).
Previous studies of the cytokine profiles of ACD indicate
that cytokine profiles are consistent with a Th1-lymphocyte-
dominant, hapten-specific immune response (Watanabe
et al., 2002). Our semi-quantitative analysis using real-time
PCR analysis of the lymphokine profiles of the elicitation
phase of ACD indicated very strong expression of Th1-
lymphokine (IFN-g) transcripts in the psoriasis and CD1
biopsy specimen and significantly lower Th2-lymphocyte (IL-4)
transcripts with the remaining four biopsy specimens
revealing equivalent Th1–Th2 lymphokine transcripts (CD2)
or significantly greater Th2 lymphokine transcripts (CD3–5)
(Figure 1c and d). These data suggest that Th1-lymphokine
transcript expression in the elicitation phase of ACD is not
uniformly a Th1-lymphocyte dominant event. These cytokine
analysis profiles were derived from skin biopsy specimens
from five different allergens in five different patients. It is not
clear whether it is the nature of the allergens or individual
patient-related factors that were responsible for the apparent
Th1- or Th2-lymphocyte-dominant cytokine profiles in these
biopsy specimens.
A nested PCR was used to first detect Va24 gene
expression and then to detect JaQ rearranged gene segment
of the T-cell receptor (Norris et al., 1999). This specific
segment of the TCR is uniquely detected in invariant human
NKT cells. Because this nested PCR represented two rounds
of amplifications of cDNA, appropriate control studies were
initiated to confirm that the PCR products amplified appro-
priate cDNA sequences. First, RNA was extracted and cDNA
was synthesized from a bulk NKT cell line derived from
peripheral blood (Norris et al., 1999) (positive control);
cultured monolayers of KCs, fibroblasts, and a transformed
Jurkatt T-lymphocyte cell line (a non-NKT cell line) were
Table 1. Patients, allergens and studies performed
Patient
no.1
Age (years)/
race/gender
Allergen/scoring/
duration2 Studies3
CD1 36/white/male Gold/2+/96 h PCR
CD2 49/black/female PPD/2+/48 h PCR/ICC/FC
CD3 40/white/male Balsam of Peru/1+/48 h PCR
CD4 53/white/male Epoxy resin/1+/48 h PCR/ICC/FC
CD5 57/white/male Rhus antigen/3+/72 h PCR
CD6 71/white/female NiSO4/2+/96 h ISH/ICC/FC
CD7 63/white/male Thimersal/2+/96 h ISH/ICC
CD8 55/oriental/male Diazolidinyl urea/2+/48 h ISH/ICC/FC
CD9 47/white/male Epoxy resin/2+/96 h ISH/ICC/FC
CD10 26/black/male Neomycin/2+/48 h ISH/ICC/FC
1Patient no. refers to contact dermatitis patients no. 1–10.
2Scoring refers to North American contact dermatitis group scoring
system; duration refers to duration of patch test when skin biopsy
specimen was obtained.
3Studies refers to PCR, ICC (immunocytochemistry), FC (flow cytometry
on peripheral blood).
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synthesized as well. All of these latter cells served as a
negative control. As expected, the nested PCR only amplified
expected PCR products from the NKT cell line, but not from
KC, fibroblasts, or transformed Jurkatt T-lymphocytes (Figure
2a). Having demonstrated the specificity of this nested PCR,
cDNA from normal skin or paired ACD samples or a psoriasis
lesion was amplified. In the psoriasis lesion, but not normal
skin, as well as in all the five ACD specimens, the gene
encoding the Va24-JaQ segment was detected (Figure 2b).
The same tissue specimens were studied utilizing real-time
PCR and SYBR green to quantify the relative increase in gene
expression in psoriasis and ACD relative to the paired normal
skin. There was a robust increase in the gene encoding the
Va24-JaQ segment in all cases of ACD (ranging from 2- to 92-
fold more than in the paired normal control skin) (Figure 2c).
Interestingly, in four out of five ACD specimens, the fold
increase was greater than that of the psoriasis lesion (12.7-
fold more than in control). These data again confirm that
there is infiltration of Va24-JaQ gene-expressing cells
infiltrating into ACD challenge sites.
Next, the PCR data was confirmed by in situ double
immunostaining. We performed double staining to confirm
that Va24 was paired with Vb11 (classical, invariant NKT
cells). In all ACD specimens studied, all Va24-bearing T cells
(green stain) co-expressed Vb11 (red stain), indicating that
they were invariant NKT cells (see overlays in Figure 3a and
b). Next, we used double staining to estimate the frequency
of NKT cells among all infiltrating lymphocytes. There
were many more CD2 single positive cells (conventional
T cells) in the infiltrate than there were double positive cells
(NKT-cells). Using digital image analysis to count single
positive (CD2, red) and double positive (CD2, red, and Va24
or Vb11, green, resulting in a yellow stain on overlays), the
frequency of NKT cells among the total T lymphocyte
infiltrate was estimated (Table 2). Among the six biopsy
specimens studied, the overall frequency of NKT cells among
the total T-cell infiltrate was low, ranging from 1.72% to as
high as 33.0% (median value 5.8%). When Vb11/CD2
double staining was utilized to estimate NKT-cell frequencies
in biopsy specimens of the elicitation phase of ACD, on these
same specimens, similar NKT-cell frequencies were noted
(Table 2). The mean frequency of Va24/CD2 double-positive
cells was not significantly different than the frequency of the
Vb11/CD2 double-positive cells (Table 2), indicating good
agreement with the estimation of NKT-cell frequency with the
two TCR-specific mAbs. These immunohistochemistry data
confirm the PCR data that NKT-cells are present in all cases of
ACD studied. In most cases, the frequency was relatively low
(CD2, 4, 6, 8, 10), except for CD9, in which the frequency
was 33.0%. Flow cytometry of peripheral blood specimens
taken at the time of the patch testing confirmed that a
localized dermatitis did not affect the frequency of NKT cells
(Va24/CD2 double-positive lymphocytes) in the peripheral
blood (Table 2). The comparison of the NKT-cell frequencies
in the contact dermatitis sites and the peripheral blood
confirm the enrichment of the NKT-cells at these allergic
reactions.
Next, the relative gene expression of Va24 (NKT cells) was
compared to that of the total T-cell infiltrate (using epsilon
chain of the CD3 antigen complex (CD3 e) as a marker for all
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Figure 1. Gene expression profiling in ACD. Real-time PCR comparing CD1d gene expression in normal skin (NORM), psoriasis (PSOR) and five cases
of ACD (CD1–5). In each case, the biopsy specimen from psoriasis or contact dermatitis was compared to the paired normal control from the same patient.
For the sake of simplicity, all six normal skin controls are represented as pooled data (NORM). (a) CD1d. (b) CD161; (c) IFN-g; (d) IL-4. (*Po0.05;
**Po0.001, compared to normal skin, ANOVA). The data depicted represent mean±SD for all real-time PCR experiments).
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TCR-bearing lymphocytes) (Hassan-Zahraee et al., 1998)
(Figure 4). Rather than using a nested PCR with two rounds of
amplification as in Figure 2, a single round of amplification to
identify Va24 TCR gene expression was utilized, under
conditions that were identical to that used to amplify CD3
e-chain gene (see Materials and Methods). Thus, these
semi-quantitative data were comparable. There was robust
CD3 e-chain gene expression in all the five CD skin biopsy
specimens compared to paired normal skin (Figure 4a). Va24
TCR gene expression was also detected (Figure 4b), but at a
lower level than that of CD3 e chain. When comparing the
relative abundance of steady-state mRNA of Va24 to that of
CD3 e in the five biopsy specimens of CD (ratios of relative
gene expression Va24/CD3100), the range was 3.12–30%,
with a median value of 11.11%. This relative abundance of
Va24 mRNA (compared to CD3 e) is remarkably similar to
that of the estimated frequency of NKT cells using double
staining (Table 2). These data confirm the presence of NKT
cells at varying levels in CD skin lesions at relatively low
levels, compared to the total infiltrate of T cells.
We studied the cytokine gene expression in NKT cells
utilizing ISH with fluorescent-labeled oligoprobes to detect
Va24 gene expression (fluorescein labeled) and oligoprobes
to detect IFN-g (rhodamine labeled) and/or IL-4 expression
(rhodamine labeled). Thus, frozen sections were double-
hybridized with Va24 (green probe) to identify NKT cells as
well as IFN-g (red probe) or IL-4 (red probe). Biopsy samples
from five ACD elicitation skin sites were studied. As
demonstrated in Figure 5, NKT cells (as defined by Va24
gene expression by in situ labeling) expressed transcripts for
both IFN-g (Figure 5a) and IL-4 (Figure 5b). There was a
remarkable consistency in the expression of both cytokine
transcripts (IFN-g and IL-4) in NKT cells from all the five
specimens studied (data not shown). These data indicate that
NKT cells are in an activated state in skin lesions of the
elicitation phase of ACD.
Our in situ immunostaining of CD1d expression in ACD
elicitation sites indicated that epidermal KCs as well as
infiltrating mononuclear cells expressed CD1d, providing the
potential to present glycolipids to NKT cells in the skin and to
trigger cytokine secretion. Therefore, we studied antigen
presentation by CD1d-bearing KCs as well as CD1d bone-
marrow-derived cells. NKT cells incubated with KCs and
a-galactosylceramide did not secrete either IFN-g or IL-4 as
measured by a sensitive ELISA (Figure 6a). In contrast, THP-1,
a monocyte-derived cell line, triggered robust IFN-g secretion
(Figure 6a) as well as significant IL-4 secretion (Figure 6b). To
confirm the ELISA data, in parallel, we extracted total cellular
RNA from NKT cells in this experiment and assayed IFN-g
and IL-4 gene expression using real-time PCR (Figure 6c and
d). This sensitive PCR confirmed that NKT cells were
triggered to activate IFN-g and IL-4 gene expression in the
presence of CD1dþ monocyte cell line and a-galactosylcer-
amide, but not by CD1d-bearing KCs. Thus, our observation
that NKT cells infiltrating in ACD lesions expressed both IFN-g
and IL-4 transcripts suggests that these cells are likely to be
activated by professional APCs, rather than KCs, which fail to
trigger cytokine production, and may result in a state of
immune tolerance.
DISCUSSION
Previous studies of the role of NKT cells in CHS have focused
on experimental mouse models, using inbred mice and
strong, Th1-lymphocyte-polarizing haptens such as oxaza-
lone as the sensitizing agent (Askenase, 2001; Campos et al.,
2003; Stein-Streilein, 2003; Nieuwenhuis et al., 2005). These
studies indicated a role for this cell type in the early
molecular events of CHS, in which NKT cells respond to
hapten application and interact with B-1 lymphocytes,
resulting in production of hapten-specific IgM (Campos
et al., 2003). Another animal model study confirmed the
role of NKT cells in murine CHS with impaired contact
sensitization in Va14 gene-targeted mice and examined the
therapeutic role of antagonistic lipids that bound to CD1d but
do not activate NKT cells (Nieuwenhuis et al., 2005). Such
antagonistic lipids, when administered topically to mouse
skin or when administered systemically, interfered with both
the afferent and efferent phases of CHS (Nieuwenhuis et al.,
2005), suggesting that inhibition of CD1d-antigen-presenting
pathway to NKT cells interfered with both phases of CHS.
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Figure 2. Unique Va24JaQ NKT-associated TCR gene expression occurs in
ACD, but not in normal skin. Nested PCR to detect unique Va24-JaQ
TCR sequences in skin biopsy specimens. RNA was extracted from an NKT
cell line, Jurkat cells, and foreskin KC (FSKC), cDNA was synthesized,
subjected to the nested PCR, and run on an agarose gel as described in
Methods. (a) Control lane (Ctrl) represents no cDNA added to nested PCR.
(b) This same nested PCR was applied to normal skin (NORM), psoriasis
(PSOR) and five cases of ACD (CD1–5). (c) Nested PCR from same specimens
was subjected to real-time PCR amplification, with SYBR green as the
fluorochrome (*Po0.05; **Po0.001; ***Po0.01, compared to normal
skin, ANOVA).
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A direct inhibitory effect on CD1d-dependent presentation of
glycolipids to NKT cells was not demonstrated.
In this study, we demonstrate that human invariant NKT
cells regularly appear in the lymphocytic infiltrate that occurs
during the elicitation phase of human ACD, either at the 48 or
96 hours time frame of clinical readings of this skin reaction.
Immunohistochemistry (Figure 3) as well as real-time PCR
and a nested PCR confirmed the presence of NKT cells in the
cellular infiltrate of ACD (Figure 2). In healthy adults, NKT
cells are present at a very low frequency in the peripheral
blood, approximately 0.1% of the total population of
peripheral blood leukocytes (Lee et al., 2002). Considering
that we demonstrated the frequency of NKT cells in the ACD
lesions to range from 1.72 to as high as 33% of the total
CD2þ infiltrating T lymphocytes, this represents a relative
enrichment of NKT cells ranging from a 17- to 330-fold
enrichment above the normally very low frequency found in
the peripheral blood. This suggests that NKT cells may be
a b
Figure 3. Va24þ /Vb11þ NKT cells are detected in ACD skin biopsy specimens by immunohistochemistry. Frozen sections from skin-biopsy specimens
of ACD were double-stained with anti-Va24 and Vb11. (a and b) Double staining of two different biopsy specimens (CD2 and 4) revealed that all Vb11
(red, top panel)-bearing T cells also expressed Va24 (green, middle panel); overlay (orange-yellow, bottom panel) (bar¼ 10 mm).
Table 2. Frequency of NKT cells in the skin and the blood of patients with CHS
Frequency of NKT in skin1
(%)
Frequency of NKT
in blood2 (%)
UPN Allergen NACDG score/duration (h) Va24 Vb11 Va24
CD2 Paraphenylene
diamine
2+/48 1.72 1.50 o0.1
CD4 Epoxy resin 1+/48 5.50 5.00 o0.1
CD6 NiSO4 2+/96 3.50 4.20 o0.1
CD8 Diazolidinyl urea 2+/96 5.80 7.00 o0.1
CD9 Epoxy resin 2+/48 33.00 29.00 o0.1
CD10 Neomycin 2+/48 4.50 6.50 o0.1
Average frequency in skin lesions (±SD) 9.00±8.86 11.803±10.05
NACDG, North American contact dermatitis group; UPN, unique patient number.
1Frequency of double-positive cells=(frequency of Va24/CD2 or Vb11/CD2 double-positive cells/total no. of CD2 single-positive cells) 100.
2Estimation by two-color flow cytometry of NKT cells (Va24/CD2 double-positive lymphocytes) in peripheral blood.
3P=0.36, not statistically significant on unpaired t-test.
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specifically recruited into ACD sites, rather than a passive
extravasation event, in which relative enrichment of fre-
quency relative to other cell types would be expected not to
occur. This recruitment of NKT cells into positive patch test
reactions is remarkably similar to what has been reported for
the recruitment of urushiol-specific conventional T lympho-
cytes into positive urushiol patch tests (10- 100-fold increase
in the clonal frequency of allergen-reactive T cells above that
found in the peripheral blood) (Kalish and Morimoto, 1989;
Kalish, 1990; Kalish and Johnson, 1990). An alternative
explanation for the increase in NKT cells would be a local
expansion of this cell type.
Our immunohistochemical studies of normal skin did not
detect Va24-bearing cells in normal skin (data not shown).
Considering that normal human skin is a rich source of
peripheral T lymphocytes (Clark et al., 2006), our observation
indicates that NKT cells play a special surveillance role to be
mobilized into, but not to reside in, normal human skin. Our
finding of NKT cells in the elicitation sites of ACD is a
remarkably constant event that occurred in the skin from 10
different volunteers in response to 9 different allergens
derived from naturally occurring percutaneous exposures
that resulted in a symptomatic allergic state (CHS). These
observations in humans demonstrate the existence of NKT
cells in CHS, which complements the experimental murine
model, in which a limited number of strong, experimental
haptens were studied using inbred mice.
We utilized psoriasis as a disease control, because a
number of studies have demonstrated the presence of NKT
cells in the cellular infiltrate of this disease, mainly in the
dermis, but also in the epidermis of mature skin lesions or at
the leading edge of developing skin lesions (Cameron et al.,
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Figure 4. CD3 gene expression is more robust than Va24 expression in ACD skin biopsy specimens. Real-time PCR was utilized to detect (a) CD3 e
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Figure 5. Infiltrating NKT cells in ACD express both transcripts for the cytokines IFN-c and IL-4. ACD skin-biopsy specimens studied by ISH: double-
labeled with antisense oligoprobes for Va24 (left panel, green; middle panel, cytokine (a) (IFN-g) or (b) IL-4 (red); right panel, overlays) (bar¼ 10mm).
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2002; Vissers et al., 2004; Bovenschen et al., 2005; Liao
et al., 2006; Ottaviani et al., 2006). Estimated frequencies
indicated that cells bearing NKT markers may be present in as
high as 10% of total CD3þ T lymphocytes (Liao et al., 2006).
Activated NKT cells can be injected into symptomless skin
from psoriasis patients that had been transplanted onto severe
combined immunodeficient mice, and they induce the
clinical and histologic features of psoriasis (Nickoloff et al.,
1999). These data suggest that NKT cells can be pathogenic
in this common skin disease. A number of studies have
indicated that NKT cells are present in inflammatory infiltrate
of both early and mature lesions of psoriasis (Cameron et al.,
2002; Vissers et al., 2004; Bovenschen et al., 2005; Liao
et al., 2006; Ottaviani et al., 2006). Our studies of the
elicitation phase of ACD indicate that a similar persistent
population of NKT cells is commonly present. These
data complement previous studies that suggested that
NKT cells play an indispensable role in the early molecular
events (within hours) in the afferent phase of CHS (Campos
et al., 2003).
Our frequency analysis of NKT cells indicated that the
frequency of NKT cells in ACD may be similar to that
previously reported in psoriasis (Liao et al., 2006). Consider-
ing the proposed pathogenic role of NKT cells in psoriasis
(Nickoloff et al., 1999), and the striking parallels we have
identified in ACD with psoriasis (presence, distribution, and
frequency of NKT cells in lesions), it is worth considering that
NKT cells contribute to the pathophysiology of the elicitation
phase of human CHS. Previous studies suggested that NKT
cells played an indispensable role in the early molecular
events of CHS (Campos et al., 2003). Our data indicate that
NKT cells play an important role in the efferent phase of CHS,
even at later phases of this allergic inflammation (NKT cells
being present in the skin of elicitation sites at either the 48 or
96 hours readings).
Analysis of cytokine gene expression in five ACD speci-
mens indicated the presence of both IFN-g and IL-4 in all
specimens studied, with variability in the relative increases in
IFN-g and IL-4 among the five specimens. Both of these
cytokines have been demonstrated to play an important role
in the pathophysiology of ACD. For IFN-g, previous studies
have focused hapten-specific Th1 and Tc1-mature, peripheral
TCR a/b-bearing lymphocytes as the source of these cytokines
in local lymph nodes and skin (Xu et al., 1996, 1997;
Watanabe et al., 2002).
For IL-4, there have been conflicting data concerning
the role of this cytokine in experimental mouse systems. In
IL-4 gene-targeted mice, there is impaired ACD to certain
haptens (Weigmann et al., 1997; Traidl et al., 1999).
Other haptens, such as fluorescein isothiocyanate, elicit a
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Figure 6. CD1dþ Monocytic APCs, but not CD1dþ KC, induce cytokine gene expression and secretion by NKT-cells in vitro. A polyclonal NKT cell line was
cultured with the CD1dþ cell line, THP-1 or CD1dþ KC (differentiated or undifferentiated, and treated with IFN-g, see Methods) in the presence (a and b) or
absence (data not shown) of a-galactosylceramide for 24 hours, and supernatants were harvested for specific luminex assay. (a) IFN-g; (b) IL-4. In another
experiment, the NKT cells were isolated after 6 hours of incubation with the above cell lines, and RNA was extracted, cDNA was synthesized, and gene
expression was studied by (c) real-time PCR IFN-g; (d) IL-4. (*Po0.05; **Po0.001, compared to control, unstimulated NKT cells, ANOVA).
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Th2-dominant response (Tang et al., 1996). Additionally,
sensitization with strong Th1-polarizing haptens followed
by repeated elicitations over time results in a transition
from the initial strong Th1-lymphocyte responses to that of a
Th2-dominant immune response (Kitagaki et al., 1997).
Studies of the gene expression profiles in the elicitation
phase of human ACD to urushiol have indicated that there is
both IFN-g and IL-4 gene expression in the skin (Ryan and
Gerberick, 1999).
Our cytokine profiles are consistent with these observa-
tions, in that we observed both IFN-g and IL-4 in all the
specimens studied (Figure 1). Our ISH studies (Figure 5)
indicate that NKT cells contribute to this cytokine profile,
in that we detected both IFN-g and IL-4 gene expression in the
infiltrating NKT cells in the elicitation phase of ACD. Our
in vitro studies with NKT cells indicate that only professional
APCs (CD1dþ THP-1 monocyte cell line) were able to trigger
both cytokines, but IFN-g secretion and gene expression were
much more robust than the low-level IL-4 gene expression and
cytokine secretion (Figure 6a–d). KCs did not trigger cytokine
secretion or cytokine gene expression by NKT cells.
Correlation of in vitro studies of NKT-cell activation and
their in situ gene expression suggests that NKT cells have
been activated by professional APCs, because they express
both IFN-g and IL-4 transcripts, which is identical to the
pattern observed when NKT cells are activated by profes-
sional APCs in vitro (Figure 6c and d). The inability of KCs to
trigger cytokine production by NKT cells is remarkably
similar to their inability to trigger cytokine secretion and
clonal proliferation by conventional TCR a/b-bearing Th1
lymphocytes (Gaspari and Katz, 1988).
Future studies will determine whether KCs induce NKT-cell
clonal anergy as has been demonstrated for CD4þ Th1
memory lymphocytes (Gaspari et al., 1988). In ACD skin biopsy
specimens, the ISH studies of cytokine mRNA expressed by
Va24þ NKT cells indicated that these cells were not anergic
because they expressed both IFN-g and IL-4 transcripts. This
suggests that professional CD1dþ APCs may have activated
NKT cells rather than tolerogenic CD1dþ KCs.
These data indicate that NKT cells represent a significant
component of the lymphocytic infiltrate of CHS, because they
were detected in elicitation sites of all the 10 skin biopsy
specimens. Furthermore, NKT cells contribute to the cytokine
gene expression profiles generated in ACD, of both IFN-g and
IL-4. The nature of the endogenous glycolipids released/
generated during the elicitation phase of ACD remains to be
determined. Previous investigators have hypothesized that
the lymphocytes migrating into skin lesions of ACD were
autoreactive T lymphocytes (Kalish, 1991).
Our data are consistent with this hypothesis, in that NKT
cells have been demonstrated to react to self-lipids, and thus
they may be reacting to self-glycolipids released during ACD.
MATERIALS AND METHODS
RNA extraction, cDNA synthesis, and real-time PCR (RNeasy
Mini Protocol, Qiagen, Valencia, CA)
Skin biopsy specimens from paired clinically normal skin and
elicitation sites of ACD were snap-frozen in liquid nitrogen and
stored at 701C until RNA extraction. RNA was extracted and cDNA
was prepared, using previously published methods (Fishelevich
et al., 2006). Real-time PCR (LightCycler, Roche, Indianapolis, IN)
was used to confirm differences in the levels of expression of
selected mRNA. The primers, PCR protocol, and product quantifica-
tion for 18S ribosomal RNA were exactly as reported previously
(SYBER green detection) (Schmittgen and Zakrajsek, 2000). All other
primers and hybridization probes were designed and prepared by
TIB Molbiol (Adelphia, NJ). The hybridization probes were labeled
with fluorescein at the 50 terminus (3FL) and with LightCycler Red at
the 50 terminus of the other probe. Amplification (40–50 cycles) of a
single PCR product was confirmed by gel electrophoresis and
melting curve analyses. The sequences of the sense and antisense
and internal hybridization probes are available as Supplementary
materials. The cDNAs were assayed in duplicate, and mean±SD
values are depicted in the graphics for the quantitative PCR.
PCR
Detection of CD1d mRNA was performed using RT-PCR. Sequences
of the primers were as follows: exon 2—sense, 50-CTG CAG ATC
TCG TCC TTC GCC AAT-30; exon 3—antisense, 50-TTG AAT GGC
CAA GTT TAC CCA AAG-30. These primers amplified a 400 bp
product using an annealing temperature of 551C and 35 cycles of
PCR. The PCR products were run on an agarose gel and
photographed. These primers have been demonstrated to be specific
for CD1d and do not amplify CD1a, CD1b, or CD1c (Bonish
et al., 2000).
Analysis of Va24-JaQ TCR gene expression
The expression of Va24-JaQ TCR gene was performed using a nested
PCR amplification technique exactly as described previously (Norris
et al., 1999). In Figure 4, the second round of amplification with the
Va24-JaQ oligonucleotide primers was eliminated. The amplifica-
tion proceeded for 40 cycles of amplification, which was identical to
the conditions utilized to amplify CD3 e chain (see above for the
sequence of oligonucleotide primers).
ISH
ISH was utilized to detect cytokine gene expression by NKT cells.
This was accomplished with a double hybridization procedure: a
green probe to detect Va24 gene expression and a red probe to
identify IFN-g or IL-4 expression. Thus, double-labeled cells (yellow
color) resulted from double hybridization with the dual probe sets.
Gene expression was detected using GeneDetect (Auckland,
New Zealand) oligonucleotide probes directly labeled with Green-
Star* fluorescent dyes. For ISH, 16 mm frozen sections were cut on a
cryostat and mounted onto poly-L-lysine-coated slides. The slide
sections were fixed in 4% paraformaldehyde, then washed with
0.1 M phosphate buffer, and then the slides were incubated with
100% ethyl alcohol for 5 minutes. Hybridization buffer (20 SSC
(solution of NaCl and Na citrate), dextran, and formamide) were
mixed and heated to 371C, and hybridization probes were added (at
a concentration of 400 ng ml1; except for polyDT, which was at
200 ng ml1). The slides were then incubated with the probe
(approximately 50 ml per slide section) and the tissue sections were
covered with parafilm and incubated in a plastic chamber overnight
at 371C (approximately 18 hours). Post-hybridization washes were
done with 1 SSC and subsequent washes with 0.5 SSC.
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The sections were then rinsed with distilled, deionized H2O and
vectashield (Vector labs) was added as an antifading agent. The
slides were examined under a fluorescent microscope and photo-
graphed. The sequences of the ISH Probes are available as
Supplementary materials.
Specificity controls were as follows: (1) RNase digestion of the
tissues before ISH prevented polyDT or specific probe hybridization;
(2) sense probes were utilized and did not bind to the tissue; (3) 10
unlabeled antisense probe blocked the hybridization of the
fluorescent labeled antisense probe. Before studying the expression
of Va24, IFN-g, or IL-4, all the tissue sections were probed with
polyDT (either FITC or Rhodamine) to assure the integrity of the RNA
in the tissue specimens.
mAbs
The following mAbs were used for the immunohistochemical
staining of frozen sections or for flow cytometry: CD1d (Nor 3.2,
Biosource, Camarillo, CA), CD2 (RPA-2.1, BD Pharmingen, San
Diego, CA), CD161 (DX12, Ancell-Alexis Biochemicals, San Diego,
CA), Va24 (C15, Immunotech, Fullerton, CA), Vb11 (C21, Immu-
notech, Fullerton, CA), HLA-DR (TU36, BD Pharmingen, San Diego,
CA). Cryostat sections (5 mm thick) of skin biopsy specimens were
processed and stained as described previously (Fishelevich et al.,
2006). For the two-color staining of the Va24 and Vb11 expression,
the Vb11 antibody (C21, mouse IgG2a) was followed by goat anti-
mouse IgG rhodamine-conjugated, followed by 10% normal mouse
serum as a blocking agent. This was followed by the Va24 antibody
(C15, IgG1), followed by a specific biotinylated goat anti-mouse
IgG1 and then by 1:100 dilution of streptavidin-conjugated FITC.
Appropriate combinations of relevant antibodies and secondary
antibodies or secondary antibodies alone demonstrated that the
immunostaining was specific (not shown). The stained slides were
examined with a Nikon Eclipse E600 epifluorescence microscope
equipped with a digital camera (RT-spot slider, Diagnostic Instru-
ments Inc., Sterling Heights, MI) and photographed at the indicated
magnifications.
Flow cytometry
For flow cytometry of peripheral blood mononuclear cells, blood
was drawn and centrifuged over lymphoprep using standard
methods (Fishelevich et al., 2006). The stained cell suspensions
were then analyzed by a Coulter EPICS Elite ESP flow cytometer.
Viable leukocytes were identified by forward and side-scatter
properties, with dead cells being excluded from analysis. A total of
100,000 events from each sample were analyzed. NKT cells were
defined as double-positive cells (Va24þ /CD2þ ).
NKT-cell assay
A highly enriched cell line (498% Va24 positive) was developed
using previously published methods (Motsinger et al., 2002).
Cultured KCs were derived from foreskins and cultured in serum-
free medium containing low (0.05 mM) or high (1.20 mM) CaCl2. KC
culture was performed as published previously (Fishelevich et al.,
2006). Twenty-four hours before co-culture with NKT cells, the KC
monolayers were treated with IFN-g (500 U ml1) to increase CD1d
cell-surface expression. The KCs were trypsinized into single-cell
suspensions and co-cultured with NKT cells at the indicated
numbers (Figure 5) in a 96-well, round-bottomed plate in a 5%
CO2 atmosphere at 371C for 24 hours in RPMI 1,640 with 10% fetal
calf serum. After 24 hours, cell-free culture supernatants were
collected and were frozen at 201C until a specific cytokine
immunoassay was performed. A luminex-based assay was utilized to
determine IFN-g or IL-4 concentrations in culture supernatants
(Pickering et al., 2002).
Human subjects
Human subjects being evaluated for contact dermatitis were
recruited from our clinical practice. The criteria for enrollment of
subjects in this study was the presence of a 1–2þ score (North
American contact dermatitis group scoring system) of the patch test
allergic reaction at 48 or 96 hours clinical readings (Belsito, 2004).
Informed consent was obtained, and skin biopsy specimens were
obtained from paired clinically normal skin and the patch test reaction
sites. This study was approved by the University of Maryland Baltimore
Institutional review board, and adhered to the Declaration of Helsinki
Principles. The patients, allergens, patch test scoring, timing of
obtaining the skin biopsy specimens from the patch test skin reactions,
and studies performed on such specimens are summarized in Table 1.
One patient with plaque-type psoriasis was studied as a disease control.
A skin biopsy specimen was taken from uninvolved, clinically normal
skin as well as the edge of a psoriatic plaque.
Statistical analyses
Quantitative data were analyzed for statistically significant differ-
ences between control and treatment groups using the GraphPad
Instat Software Program (GraphPad Software, San Diego, CA).
Because multiple comparisons were examined, a one-way ANOVA
(Tukey Kramer multiple analyses) or unpaired Students’ t-test for a
simple analysis of two means were applied to the quantitative data
(Po0.05 were considered significant).
SUPPLEMENTARY MATERIAL
Supplementary Materials and Methods.
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